Aardvark Therapeutics, Inc. Common Stock AARD Cash Flow Statement
| FY'25 | ||
|---|---|---|
| -$57.59M-180% | ||
| $36K+125% | ||
| $3.95M+799% | ||
| -$54.17M-200% | ||
| $95K-12.8% | ||
| —— | ||
| $89.32M+7.6% | ||
| —— | ||
| -$54.27M-198% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aardvark Therapeutics, Inc. Common Stock generate?
- Aardvark Therapeutics, Inc. Common Stock (AARD) generated -$61.7M in operating cash flow over the trailing twelve months.
- Where does Aardvark Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Aardvark Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.